Germany's BioNTech on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol Myers Squibb in a cancer immunotherapy alliance that seeks to challenge ...
Preview this article 1 min October saw not just one, but four different M&A deals with valuations over $1 billion. Power50: The Movement Makers Join us as we celebrate the Movement Makers -- they're ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback